Page last updated: 2024-08-21

isoxazoles and Heart Defects, Congenital

isoxazoles has been researched along with Heart Defects, Congenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, J; Hama, K; Inoue, A; Kano, K; Kawahara, A; Nakanaga, K; Nishina, H; Saigusa, D; Sato, T; Tokuyama, H; Tomioka, Y; Yukiura, H1
Book, WM; Lee, EK; Lyle, TA; McConnell, ME; Mehta, PK; Simpson, L1

Other Studies

2 other study(ies) available for isoxazoles and Heart Defects, Congenital

ArticleYear
Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.
    Journal of biochemistry, 2014, Volume: 155, Issue:4

    Topics: Animals; Down-Regulation; Embryo, Nonmammalian; Heart Defects, Congenital; HEK293 Cells; Humans; Isoxazoles; Lysophospholipids; Phenotype; Phosphoric Diester Hydrolases; Propionates; Receptors, Lysophosphatidic Acid; RNA, Messenger; Signal Transduction; Sphingosine; Zebrafish

2014
Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Texas Heart Institute journal, 2008, Volume: 35, Issue:3

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Drug Administration Schedule; Eisenmenger Complex; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Exercise Test; Female; Heart Defects, Congenital; Humans; Isoxazoles; Male; Middle Aged; Oxygen; Retrospective Studies; Sulfonamides; Thiophenes

2008